NanoVibronix, Inc. (NAOV)
NASDAQ: NAOV · IEX Real-Time Price · USD
0.763
-0.012 (-1.51%)
At close: Jul 19, 2024, 4:00 PM
0.720
-0.043 (-5.64%)
Pre-market: Jul 22, 2024, 9:12 AM EDT
NanoVibronix Employees
As of December 31, 2023, NanoVibronix had 16 total employees, including 10 full-time and 6 part-time employees. The number of employees increased by 2 or 14.29% compared to the previous year.
Employees
16
Change (1Y)
2
Growth (1Y)
14.29%
Revenue / Employee
$178,125
Profits / Employee
-$200,125
Market Cap
2.12M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Nuwellis | 59 |
cbdMD | 52 |
NovaBay Pharmaceuticals | 26 |
Windtree Therapeutics | 20 |
Azitra | 10 |
Phio Pharmaceuticals | 9 |
Tivic Health Systems | 9 |
Galmed Pharmaceuticals | 8 |
NAOV News
- 2 months ago - NanoVibronix Announces Commencement of UroShield Clinical Study at the University of Michigan - Business Wire
- 2 months ago - NanoVibronix Issues Letter to Stockholders - Business Wire
- 2 months ago - NanoVibronix Announces Distribution Agreement with VA Supplier CB Medical for the Distribution of UroShield - Business Wire
- 2 months ago - NanoVibronix Announces PainShield Will Be Included in Department of Veteran Affairs' FSS Contract Award - Business Wire
- 3 months ago - NanoVibronix to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 - Accesswire
- 4 months ago - NanoVibronix Signs Agreement for Research and Development of Next Generation PainShield and UroShield - Business Wire
- 8 months ago - NanoVibronix Featured in Your Bladder Health Magazine - Business Wire
- 8 months ago - NanoVibronix Enters into Letter of Intent with APOGEPHA Arzneimittel GmbH to Explore European Distribution Opportunity - Business Wire